Evidence map›Paper›PMID 38046964›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Whole-body

Koramadai Karuppusamy Kamaleshwaran, Elumalai Ramkumar, Madhu Sairam Raghunathan

Abstract read
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Koramadai Karuppusamy KamaleshwaranDepartment of Nuclear Medicine, PET/CT and Radionuclide Therapy, Coimbatore, Tamil Nadu, India.
Elumalai RamkumarDepartment of Nuclear Medicine, PET/CT and Radionuclide Therapy, Coimbatore, Tamil Nadu, India.
Madhu Sairam RaghunathanDepartment of Radiotherapy, Kovai Medical Center and Hospital Limited, Coimbatore, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults that accounts for nearly 20% of all primary malignant brain tumors. While GBM is notable for local recurrence and invasion, extracranial metastases (ECMs) are exceedingly rare, occurring in <2% of patients. However, the report of

Indexed as

18F-fluorodeoxyglucose positron emission tomography/computed tomographyextracranial metastasesglioblastomawhole body

Identifiers

PMID38046964
PMCPMC10693363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.